2005 Annual Meeting | Assessment of Rapidly Progressive Dementias and Related Neurological Conditions

Date Saturday 04/16/05

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Michael D. Geschwind, MD, PhD, F�鶹��ýӳ��

Topic(s) Aging/Dementia/Degenerative Disease

Learning Objectives Upon completion:
Participants should be familiar with the differential diagnoses and work-up of common and uncommon diseases which may present as RPD, including Jakob-Creutzfeldt Disease (CJD) and its many imitators.

CME Available No CME available

Program Level Intermediate

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
06:45 AM - 08:15 AM		Assessment of Rapidly Progressive Dementias and Related Neurological Conditions Bradley F. Boeve, MD, F�鶹��ýӳ��, Michael D. Geschwind, MD, PhD, F�鶹��ýӳ��, Steven Vernino, MD, PhD, F�鶹��ýӳ��
06:45 AM - 08:30 AM		Breakfast
08:15 AM - 08:30 AM		Questions and Answers

Faculty Disclosures
Michael D. Geschwind, MD, PhD, F�鶹��ýӳ��	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Bradley F. Boeve, MD, F�鶹��ýӳ��	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Steven Vernino, MD, PhD, F�鶹��ýӳ��	Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.